A single oral dose of antimicrobial prophylaxis is reasonable in 12-core transurethral ultrasound (TRUS)-guided prostate biopsies, researchers have concluded.

In a study by Kamil Cam, MD, and collaborators at Duzce University School of Medicine in Duzce, Turkey, 400 patients who underwent 12-core TRUS-guided prostate biopsies were randomly assigned to one of three groups based on their antibiotic prophylaxis regimen. One group of 139 patients received 1 g of IM ceftriaxone, another group of 131 patients received a three-day course of oral ciprofloxacin, and the third group of 130 patients received a single oral 500-mg dose of ciprofloxacin.

Urine cultures were obtained prior to biopsy and on the second day following biopsy. Overall, only seven patients (1.8%) had positive urine cultures after biopsy, with no differences observed among the three groups, Dr. Cam’s team reported in the International Journal of Urology (2008; published online ahead of print).


Continue Reading

In addition, the investigators found no significant difference in morbidity rates among the groups. Major complications requiring hospitalization developed in only eight patients (2%), the investigators reported.